Rennova Health (RNVAD) Stock Price, News & Analysis

Company Overview

Rennova Health, Inc. is a U.S.-based healthcare services holding company that operates through a network of specialty pharmacy and medical management subsidiaries. The company provides a range of outsourced services to payers, providers and patients, including medication therapy management, specialty medication distribution and clinical program support for chronic and complex conditions.

Through its affiliated specialty pharmacy platform, Rennova Health offers tailored dispensing services, patient adherence programs and integrated clinical support, aiming to optimize therapeutic outcomes and reduce total cost of care. The company also leverages telehealth and remote patient monitoring solutions to enhance its service offerings and improve care coordination.

Established through the consolidation of multiple healthcare service providers, Rennova Health has expanded its footprint across the United States, serving commercial and government-sponsored healthcare programs. Its leadership team draws on extensive experience in pharmacy operations, managed care and healthcare technology to drive growth and operational excellence.

Rennova Health continues to pursue strategic acquisitions and partnerships to broaden its service capabilities, with a focus on delivering end-to-end solutions that address the evolving needs of patients, providers and payers in the specialty pharmacy market.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 1.28 million shs
• Market Capitalization: $318.79 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 8/20/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: General Medical & Surgical Hospitals
• Sub-Industry: Healthcare
• Current Symbol: OTCMKTS:RNVAD
• CIK: 931059
• Web: www.rennovahealth.com
• Phone: 561-855-1626
• Fax: 415-248-5351
• Employees: 60
• Year Founded: 1995

Profitability

• EPS (Trailing Twelve Months): ($234.37)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$18.34 million
• Net Margins: N/A
• Pretax Margin: -476.63%
• Return on Equity: N/A
• Return on Assets: -77.55%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.05
• Quick Ratio: 0.05

Sales & Book Value

• Annual Sales: $7.20 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 44,276,552,000
• Free Float: 19,694,210,000
• Market Cap: $318.79 million
• Optionable: Not Optionable
• Beta: 18.08